Responses
Clinical and epidemiological research
Concise report
Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up
Compose a Response to This Article
Other responses
No responses have been published for this article.